Penta is the coordinator for the newly funded EDCTP project – UNIVERSAL! Later in the day, we will be speaking with partners at the official kick-off meeting.
UNIVERSAL will develop, evaluate and register two new antiretroviral formulations for infants and children newly diagnosed with HIV initiating antiretroviral therapy, and for children failing first-line therapy who need to switch to a new treatment regimen.
